## MKTX: MarketAxess Holdings, Inc. - XLF: Financial Services

### Executive Summary

PARABOLIC warning: MRS_10 at 6.1% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($168.67)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. MKTX Sets 2026-2028 Growth Targets, Boosts Share Buybacks**
- Source: The Globe and Mail | 20251211T000821 | Bullish | Relevance: 99%
-  MarketAxess Holdings Inc. (MKTX) has announced new financial targets for 2026-2028, aiming for 8-9% average annual revenue growth and a 75-125 basis point improvement in operating margin, driven by sustained technology investments and growth in credit market average daily volume. The company also authorized an additional share repurchase program of up to $400 million, bringing its total repurchase capacity to $505 million, including an Accelerated Share Repurchase (ASR) of $300 million. This move is supported by MarketAxess's strong financial position and capital deployment history, which also includes a recent dividend hike.

**2. MKTX Sets 2026-2028 Growth Targets, Boosts Share Buybacks**
- Source: TradingView | 20251210T190839 | Bullish | Relevance: 99%
- MarketAxess Holdings Inc. (MKTX) announced medium-term financial targets for 2026-2028, aiming for 8-9% average annual total revenue growth and a 75-125 basis point improvement in operating margin. The company also authorized an additional share repurchase program of up to $400 million, bringing the total repurchase capacity to $505 million, with $300 million allocated for an Accelerated Share Repurchase agreement. These actions reflect strong management confidence in technology investments and robust financial health.

**3. MarketAxess Announces Medium-Term Financial Targets1 Increases Stock Repurchase Authorization to $505 million Intends to Effect an Accelerated Stock Repurchase**
- Source: Business Wire | 20251209T123245 | Bullish | Relevance: 99%
-  MarketAxess Holdings Inc. (Nasdaq: MKTX) announced new medium-term financial targets for 2026-2028, aiming for 8-9% average annual total revenue growth and a 75-125 basis points per year increase in operating margin. The company's Board of Directors also authorized an additional $400 million for stock repurchases, bringing the total authorization to $505 million, and plans an Accelerated Stock Repurchase (ASR) of $300 million with JPMorgan Chase Bank. These actions reflect confidence in the company's long-term strategy and commitment to driving stockholder value.

**4. MarketAxess Announces Stock Repurchase Increase**
- Source: TipRanks | 20251209T130345 | Somewhat-Bullish | Relevance: 99%
- MarketAxess Holdings Inc. (MKTX) announced an increase in its stock repurchase authorization to $505 million, reflecting confidence in its long-term strategy and commitment to stockholder value creation. The company plans an Accelerated Stock Repurchase of $300 million with JPMorgan Chase Bank, funded by cash and borrowings. MKTX is currently rated a Hold by analysts with a $183.00 price target, and Spark, TipRanksâ€™ AI Analyst, considers it a Neutral, citing strong financials but fair valuation and technical resistance.

**5. MarketAxess Holdings Inc. $MKTX Shares Purchased by Amundi**
- Source: MarketBeat | 20251210T110845 | Neutral | Relevance: 99%
-  Amundi significantly increased its stake in MarketAxess Holdings Inc. (NASDAQ:MKTX) by 61.2% in the second quarter, owning 221,802 shares valued at $48.61 million. This move is part of a broader trend, with other institutional investors like Norges Bank and Millennium Management LLC also increasing their holdings in the financial services provider. MarketAxess recently reported strong quarterly earnings, surpassing analyst estimates, and announced a quarterly dividend of $0.76 per share.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | Morgan Stanley | $209 | $247 | -15% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | Morgan Stanley | down | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (-11.6%)
- Primecap Management : 6.0% (+66.6%)
- FMR, LLC: 5.8% (-8.1%)
- Van Eck Associates C: 5.2% (+6.5%)
- Blackrock Inc.: 5.0% (-30.2%)

### Key Risks

1. Long-term trend broken: trading 10.0% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Share repurchase program provides demand floor and EPS support.
- Momentum building: MRS_10 improving +5.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.25 elevated, pricing in significant growth expectations. Forward P/E 21.8x attractive for 39% earnings growth. Quality metrics strong (ROA 11%, margin 26%). Balance sheet: strong liquidity (2.5x), low leverage (D/E 0.45). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $6.6B |
| Beta | 0.99 |
| 52W Range | $156.17 - $239.99 |
| Short Interest | 4.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.25 |
| Forward P/E | 21.8 |
| Current P/E | 30.3 |
| YoY Growth | 38.8% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from 0.9% to 6.1% (+5.2% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (6.1% > 6.0%), caution on chasing. MRS_5 at 3.6% confirms short-term momentum alignment. Outperforming sector by 4.3pp, stock-specific strength. Below SMA200 (0.90x), long-term trend not supportive. MACD histogram positive (1.72), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 6.06% (CS: 93) | Strong |
| RSI_14 | 65.3 | Neutral |
| MACD Histogram | 1.72 | Bullish |
| vs SMA20 | 1.063x | Above |
| vs SMA50 | 1.059x | Above |
| vs SMA200 | 0.900x | Below |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $177.85
- **Stop Loss:** $168.67 (5.2% risk)
- **Target:** $187.03 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 150
- **Position Value:** $26,677.50
- **Portfolio %:** 26.68%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-05 (Est: $1.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.68 | $1.84 | +9.5% |
| 2025Q2 | $1.96 | $1.91 | -2.6% |
| 2025Q1 | $1.81 | $0.40 | -77.9% |
| 2024Q4 | $1.68 | $1.73 | +3.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*